Correlation between HCV viraemia and splenic volume in chronic HCV infected patients: An Egyptian study

Arab Journal of Gastroenterology

Volumn 13, Issue 2, 2012, Pages 58-64

  Ahmed, Rasha ^a   Salama, Hosney ^a   AbdAllah, El Sayed ^a   Ahmed, Salah El Din M ^b   Sabry, Dina ^a   Omar, Dina ^a   Darwish, Tarneem ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Tropical Medicine Research Institute   (Egypt)

Author keywords

HCV RNA concentration; Interferon therapy; Splenic volume

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; CHRONIC HEPATITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPLEEN;

ADULT; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EGYPT; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; ORGAN SIZE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; RNA, VIRAL; SPLEEN; STATISTICS, NONPARAMETRIC; VIRAL LOAD; VIREMIA;

EID: 84866279024     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2012.06.001     Document Type: Article

References (24)

1. World Health Organization (WHO). Hepatitis C. World Health Organization (WHO); 2005. Fact sheet No.164.
2. Mohamad M. Epidemiology of HCV in Egypt. Afro-Arab Liver J 2004, 3(2):41-52.
3. Berry V., Arora R., Paul P. Hepatitis C - clinical outcome and diagnosis. JK Sci 2005, 7(3):129-132.
4. Mebius R.E., Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005, 5(8):606-616.
5. Swirski F.K., Nahrendorf M., Etzrodt M., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325(5940):612-616.
6. Zhu J.H., Wang Y.D., Ye Z.Y., et al. Laparoscopic versus open splenectomy for hypersplenism secondary to liver cirrhosis. Surg Laparosc Endosc Percutan Tech 2009, 19(3):258-262.
7. Lamb P.M., Lund A., Kanagasabay R.R., et al. Spleen size: How well do linear ultrasound measurements correlate with three-dimensional CT volume assessments?. Br J Radiol 2002, 75(895):573-577.
8. Bezerra A.S., D'Ippolito G., Faintuch S., et al. Determination of splenomegaly by CT: Is there a place for a single measurement?. Am J Roentgenol 2005, 184(5):1510-1513.
9. Yetter E.M., Acosta K.B., Olson M.C., et al. Estimating splenic volume: Sonographic measurements correlated with helical CT determination. Am J Roentgenol 2003, 181(6):1615-1620.
10. Mehta S.H., Cox A., Hoover D.R., et al. Protection against persistence of hepatitis C. Lancet 2002, 359(9316):1478-1483.
11. Doss W, Mohamed MK, Esmat G, et al. Egyptian national control strategy for viral hepatitis 2008-2012. National Committee for the Control of Viral Hepatitis.
12. Mackay I.M., Real-time P.C.R. In the microbiology laboratory. Clin Microbiol Infect 2004, 10(3):190-212.
13. Radonić A., Thulke S., Mackay I.M., et al. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004, 313(4):856-862.
14. Bravo A.A., Sheth S.G., Chopra S. Liver biopsy. N Engl J Med 2001, 344(7):495-500.
15. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22(6):696-699.
16. Theise N.D. Liver biopsy assessment in chronic viral hepatitis: A personal, practical approach. Mod Pathol 2007, 20(Suppl. 1):S3-S14.
17. Ishibashi H., Higuchi N., Shimamura R., et al. Sonographic assessment and grading of spleen size. J Clin Ultrasound 1991, 19(1):21-25.
18. Messinezy M., Macdonald L.M., Nunan T.O., et al. Spleen sizing by ultrasound in polycythaemia and thrombocythaemia: Comparison with SPECT. Br J Haematol 1997, 98(1):103-107.
19. Draper DJ, Ronald A, Sacher MB. Splenomegaly differential diagnosis. emedicine; 2009.
20. Tarantino G., Conca P., Tarantino M., et al. Does spleen volume play a role in patients with HCV-related chronic hepatitis?. Int J Immunopathol Pharmacol 2009, 22(4):1009-1017.
21. Lee S.S., Abdo A. Predicting antiviral treatment response in chronic hepatitis C: How accurate and how soon?. J Antimicrob Chemother 2003, 51(3):487-491.
22. Khakoo S.I., Thio C.L., Martin M.P., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004, 305(5685):872-874.
23. Thio C.L., Gao X., Goedert J.J., et al. HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002, 76(10):4792-4797.
24. Thio C.L., Thomas D.L., Goedert J.J., et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001, 184(1):16-21.